Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis

被引：136
|
作者：
Dev, Kumlesh K. [1 ,2 ]
Mullershausen, Florian [3 ]
Mattes, Henri [2 ]
Kuhn, Rainer R. [2 ]
Bilbe, Graeme [2 ]
Hoyer, Daniel [2 ]
Mir, Anis [2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
[2] Nova Pharmaceut, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland
[3] Nova Pharmaceut, Novartis Inst BioMed Res, Dept G Prot Coupled Receptors, Basel, Switzerland
来源：
PHARMACOLOGY & THERAPEUTICS | 2008年 / 117卷 / 01期
关键词：
sphingosine-1-phosphate; SIP receptor; FTY720 (fingolimod); central nervous system; multiple sclerosis;
D O I：
10.1016/j.pharmthera.2007.08.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Multiple sclerosis (MS) is an autoimmune, neurological disability with unknown etiology. The current therapies available for MS work by all immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss. Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clinical trials. This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (SIP) receptors. Here, we outline the direct roles that S I P receptors play in the central nervous system (CNS) and discuss additional modalities by which FTY720 may provide direct neuroprotection in MS. (c) 2007 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码：77 / 93
页数：17
相关论文
共 50 条
  • [31] Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice
    Klingenberg, Roland
    Nofer, Jerzy-Roch
    Rudling, Mats
    Bea, Florian
    Blessing, Erwin
    Preusch, Michael
    Grone, Hermann J.
    Katus, Hugo A.
    Hansson, Goeran K.
    Dengler, Thomas J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (11) : 2392 - 2399
  • [32] The Sphingosine-1-Phosphate Analogue FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium
    Murphy, Carola T.
    Hall, Lindsay J.
    Hurley, Grainne
    Quinlan, Aoife
    MacSharry, John
    Shanahan, Fergus
    Nally, Kenneth
    Melgar, Silvia
    INFECTION AND IMMUNITY, 2012, 80 (08) : 2712 - 2723
  • [33] Effects of sphingosine-1-phosphate and FTY720 on epidermal hyperproliferation and inflammation in an imiquimod induced mouse model of psoriasis
    Schaper, K.
    Kietzmann, M.
    Kleuser, B.
    Baeumer, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 80 - 80
  • [34] Lusitropic and anti-hypertrophic effects of the sphingosine-1-phosphate receptor modulator, FTY720, in hypertrophic cardiomyopathy
    Ryba, D. M.
    Warren, C. M.
    Karam, C. N.
    Davis, R. T., III
    Chowdhury, S. A. K.
    Alvarez, M. G.
    Wieczorek, D. F.
    Solaro, R. J.
    Wolska, B. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 12 - 12
  • [35] Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis
    Pinki, Vijay Thawani
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 206 - 206
  • [36] Effect of the sphingosine-1-phosphate receptor modulator FTY720 on the outcome in a mouse model of focal cortical cryolesion
    Albert-Weissenberger, C.
    Hennig, N.
    Siren, A. -L.
    Kleinschnitz, C.
    JOURNAL OF NEUROLOGY, 2013, 260 : S119 - S120
  • [37] The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabetes in Spontaneously Diabetic Torii rats
    Kobayashi, Kazuma
    Sasase, Tomohiko
    Ishii, Yukihito
    Katsuda, Yoshiaki
    Miyajima, Katsuhiro
    Yamada, Takahisa
    Ohta, Takeshi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (06) : 869 - 876
  • [38] Induction of regulatory T cell capacities by the sphingosine-1-phosphate analogue FTY720 in TNBS-colitis
    Daniel, Carolin
    Sartory, Nico
    Radeke, Heinfried H.
    Geisslinger, Gerd G.
    Stein, Juergen M.
    GASTROENTEROLOGY, 2006, 130 (04) : A351 - A352
  • [39] Sphingosine-1-phosphate analogue FTY720 exhibits a potent anti-proliferative effect on glioblastoma cells
    Kolodziej, M. A.
    Al Barim, B.
    Nagl, J.
    Weigand, M. A.
    Uhl, E.
    Uhle, F.
    Di Fazio, P.
    Schwarm, F. P.
    Stein, M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (04) : 1039 - 1046
  • [40] The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway
    Beider, Katia
    Rosenberg, Evgenia
    Bitner, Hanna
    Shimoni, Avichai
    Leiba, Merav
    Koren-Michowitz, Maya
    Ribakovsky, Elena
    Klein, Shiri
    Olam, Devorah
    Weiss, Lola
    Wald, Hanna
    Abraham, Michal
    Galun, Eithan
    Peled, Amnon
    Nagler, Arnon
    CLINICAL CANCER RESEARCH, 2017, 23 (07) : 1733 - 1747
12345